Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-029696
Filing Date
2021-11-23
Accepted
2021-11-23 16:11:14
Documents
59
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 833724
2 ex31-1.htm EX-31.1 10485
3 ex31-2.htm EX-31.2 10214
4 ex32-1.htm EX-32.1 4649
5 ex32-2.htm EX-32.2 4585
  Complete submission text file 0001493152-21-029696.txt   4612512

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE lucd-20210930.xsd EX-101.SCH 42627
7 XBRL CALCULATION FILE lucd-20210930_cal.xml EX-101.CAL 40045
8 XBRL DEFINITION FILE lucd-20210930_def.xml EX-101.DEF 164852
9 XBRL LABEL FILE lucd-20210930_lab.xml EX-101.LAB 296193
10 XBRL PRESENTATION FILE lucd-20210930_pre.xml EX-101.PRE 245262
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 780487
Mailing Address ONE GRAND CENTRAL PLACE, SUITE 4600 NEW YORK NY 10165
Business Address ONE GRAND CENTRAL PLACE, SUITE 4600 NEW YORK NY 10165 212 949 4319
Lucid Diagnostics Inc. (Filer) CIK: 0001799011 (see all company filings)

EIN.: 825488042 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40901 | Film No.: 211438631
SIC: 3841 Surgical & Medical Instruments & Apparatus